Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.
about
The role of immune checkpoint inhibition in the treatment of ovarian cancerQuantitative mass spectrometry analysis of PD-L1 protein expression, N-glycosylation and expression stoichiometry with PD-1 and PD-L2 in human melanoma.Aligning Digital CD8(+) Scoring and Targeted Next-Generation Sequencing with PD-L1 Expression: A Pragmatic Approach in Early-Stage Squamous Cell Lung Carcinoma.Prospects for combined use of oncolytic viruses and CAR T-cells.PD-L1 expression and CD8+ tumor-infiltrating lymphocytes are associated with ALK rearrangement and clinicopathological features in inflammatory myofibroblastic tumors.Informatics for cancer immunotherapy.Ex Vivo Profiling of PD-1 Blockade Using Organotypic Tumor Spheroids.Implications of the tumor immune microenvironment for staging and therapeutics.Immunological classification of renal cell carcinoma patients based on phenotypic analysis of immune check-point molecules.Prospects to improve chimeric antigen receptor T-cell therapy for solid tumors.Vaccination with High-Affinity Epitopes Impairs Antitumor Efficacy by Increasing PD-1 Expression on CD8+ T Cells.TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti-PD-1/anti-CTLA-4 immunotherapy.Frameshift events predict anti-PD-1/L1 response in head and neck cancer.Correlation of MET gene amplification and TP53 mutation with PD-L1 expression in non-small cell lung cancer.Computational immune profiling in lung adenocarcinoma reveals reproducible prognostic associations with implications for immunotherapy.Oncograms Visualize Factors Influencing Long-Term Survival of Cancer Patients Treated with Adenoviral Oncolytic Immunotherapy.Keeping Tumors in Check: A Mechanistic Review of Clinical Response and Resistance to Immune Checkpoint Blockade in Cancer
P2860
Q28077924-459D849E-B919-468B-936A-9FA30CB8ED12Q36382143-07630616-326A-4188-8C10-539E03AE682AQ40496586-24922F92-29CC-4EC8-A0CB-EC4AFF39B254Q47103891-F52B7EB0-61C0-4499-81DE-4DBB3B264071Q47105638-634755DA-AEDB-4600-880F-DF49F93E505CQ47290509-0D29A196-5DFA-480D-9A35-B5A3730C06AFQ47382765-7A36A874-DEBD-4775-844C-60969EE78414Q47592007-88E47673-83F1-4EF4-B313-282A1CAD4A02Q47870351-C5628ABF-9BDB-4EE4-9E25-1C0F3DB2957DQ50035774-B943A19D-545D-4638-BC8F-7540289902E6Q50222492-F2595134-72AB-4CE1-B444-583461068EE9Q52316792-86E73228-118E-4FEB-8629-3BDAD25BAC50Q54269200-45135039-DDCC-4B57-872F-B463BA87181EQ55177170-D7D93F29-A2E9-4F22-8117-F97C28C69AC5Q55314488-71A8E8DB-5D75-4CA7-A2FC-1137ACF4CB0DQ55510561-27728CB2-1CBA-4911-8A50-47807E50BB77Q56891212-90B58E77-26D3-407D-AB43-0B9BCC653E44
P2860
Multiparametric profiling of non-small-cell lung cancers reveals distinct immunophenotypes.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 08 September 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Multiparametric profiling of n ...... als distinct immunophenotypes.
@en
Multiparametric profiling of n ...... als distinct immunophenotypes.
@nl
type
label
Multiparametric profiling of n ...... als distinct immunophenotypes.
@en
Multiparametric profiling of n ...... als distinct immunophenotypes.
@nl
prefLabel
Multiparametric profiling of n ...... als distinct immunophenotypes.
@en
Multiparametric profiling of n ...... als distinct immunophenotypes.
@nl
P2093
P2860
P1433
P1476
Multiparametric profiling of n ...... als distinct immunophenotypes.
@en
P2093
Abigail Santos
Adam J Bass
Anil K Rustgi
Christina Almonte
Cloud P Paweletz
Donald W Kufe
Elena V Ivanova
F Stephen Hodi
Grit S Herter-Sprie
Guo-Cheng Yuan
P2860
P304
P356
10.1172/JCI.INSIGHT.89014
P577
2016-09-08T00:00:00Z